Delivery Order SPE2DP15D0006-0008
Award Date 10/28/15
Potential Completion Date 11/30/15
Potential Value $101K
Federal Agency
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Durham, NC 27709, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
6
Legislative Mandate
Clinger Cohen Act
National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award, with ID SPE2DP18D0006|SPE2DP19F0455, was issued by the Defense Logistics Agency (DLA) to the prime contractor Glaxosmithkline, LLC, a pharmaceutical company that provides vaccines, antiviral medications, and other pharmaceutical products to U.S. government agencies. The contract is for the delivery of influenza virus vaccine, with a ceiling value of $56,050. The contract type is Delivery Order with Firm Fixed Price pricing. The contract has no set-aside designation...
- This federal contract award, SPE2DP18D0006|SPE2DP19F0375, was issued by the Defense Logistics Agency (DLA) to Glaxosmithkline, LLC for the delivery of influenza virus vaccines. The $53,730.00 firm fixed price delivery order has a period of performance ending on November 7, 2018 and was placed under a larger DLA pharmaceutical supply contract vehicle. The contract does not have a set-aside designation. Glaxosmithkline, a foreign-owned for-profit pharmaceutical company, has also received other...
- This federal contract award, with ID SPE2DP16D0006|0005, was issued by the Medical Supply Chain division of the Defense Logistics Agency to Glaxosmithkline, LLC, a pharmaceutical company, for the provision of influenza virus vaccines. The $282,870.56 firm fixed price delivery order has an ultimate completion date of November 30, 2016 and does not have a set-aside designation. Glaxosmithkline, LLC is a prime contractor that has received various federal contract and grant awards to supply...
- This is a federal contract award to Glaxosmithkline, LLC, a pharmaceutical company, from the Defense Logistics Agency (DLA) for the delivery of influenza virus vaccines. The contract has a ceiling value of $3,820.80 and is a firm fixed price delivery order with a completion date of November 12, 2018. The contract does not have a set-aside designation. Glaxosmithkline has provided a range of pharmaceutical products and services to various U.S. government agencies through federal contracts and...
- This federal contract award was issued by the Medical Supply Chain division of the U.S. Department of Defense to Glaxosmithkline, LLC, a pharmaceutical company, for the provision of influenza virus vaccines. The firm fixed price delivery order, valued at $29,850, has an ultimate completion date of October 19, 2018. The contract was not set aside for any socioeconomic category. Glaxosmithkline, LLC has also received multiple award indefinite delivery vehicles from the Centers for Disease...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to GlaxoSmithKline, LLC, a pharmaceutical company, for the provision of influenza virus vaccines. The order was issued under contract SPE2DP18D0006 and has a firm fixed price ceiling value of $17,193.60. The order was awarded on October 16, 2018, with a performance completion date of November 5, 2018. The contract does not have a set-aside designation. GlaxoSmithKline has received multiple federal contract awards and grants...
- This federal contract award with ID SPE2DP24D0005|SPE2DP24F3249 is for the delivery of influenza virus vaccines. The contract was awarded on March 14, 2024 to the prime contractor Glaxosmithkline, LLC, doing business as Glaxosmithkline, a pharmaceutical company that provides vaccines, antivirals, and other pharmaceutical products to U.S. government agencies. The contract has a ceiling value of $1,551,550.00 and is a firm fixed price delivery order contract with no set-aside designation. The...
- This federal contract award for $2,408,448.00 was issued by the Medical Supply Chain division of the U.S. Department of Defense to the pharmaceutical company Glaxosmithkline, LLC for the delivery of influenza virus vaccines. The contract is a firm fixed price delivery order with no set-aside designation, and performance will occur at Glaxosmithkline's facilities in North Carolina. This award is part of a larger indefinite delivery vehicle (IDV) contract held by Glaxosmithkline to provide a range...
- The U.S. government agency, the Medical Supply Chain, has awarded a $1,400.00 firm fixed price delivery order contract to Glaxosmithkline, LLC, a pharmaceutical company, for the provision of influenza virus vaccines. This contract has no set-aside designation and the performance will take place at Glaxosmithkline's facilities in Durham, North Carolina. Glaxosmithkline has also received several other federal contracts and grants to supply a range of pharmaceutical products and services, including...
- The Defense Logistics Agency Troop Support Medical awarded Glaxosmithkline, LLC a $5,982.80 firm fixed price purchase order to supply influenza virus vaccinations. As the prime contractor, Glaxosmithkline will deliver the requested vaccinations from its location in Durham, North Carolina, with performance under the contract spanning from September 28 to October 10, 2023. No subcontractors or set aside designations were indicated. The contract supports the Defense Logistics Agency's mission to...